Initiation of a "First in Human" Clinical Trial for an Innovat...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TOULOUSE, France, Nov. 9, 2020 /PRNewswire-AsiaNet/-- Pierre Fabre announced today the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, an innovative monoclonal antibody targeting VISTA, developed by Pier...
Authors: LATEST ASIANET NEWS RELEASES